Erik Ullerås

824 total citations
26 papers, 657 citations indexed

About

Erik Ullerås is a scholar working on Molecular Biology, Health, Toxicology and Mutagenesis and Immunology. According to data from OpenAlex, Erik Ullerås has authored 26 papers receiving a total of 657 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Health, Toxicology and Mutagenesis and 7 papers in Immunology. Recurrent topics in Erik Ullerås's work include Animal testing and alternatives (5 papers), Effects and risks of endocrine disrupting chemicals (4 papers) and Immunotoxicology and immune responses (3 papers). Erik Ullerås is often cited by papers focused on Animal testing and alternatives (5 papers), Effects and risks of endocrine disrupting chemicals (4 papers) and Immunotoxicology and immune responses (3 papers). Erik Ullerås collaborates with scholars based in Sweden, United Kingdom and Poland. Erik Ullerås's co-authors include Agneta Oskarsson, Åsa Ohlsson, Gunnar Nilsson, Nina Cedergreen, Johan Patring, M. Gulliksson, Kathryn E. Plant, Peter S. Goldfarb, J. P. Hinson and Stephen J. Miller and has published in prestigious journals such as Journal of Biological Chemistry, Blood and PLoS ONE.

In The Last Decade

Erik Ullerås

26 papers receiving 640 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erik Ullerås Sweden 16 236 170 139 105 79 26 657
Masahiro Takeyoshi Japan 15 122 0.5× 384 2.3× 165 1.2× 102 1.0× 79 1.0× 55 788
Neville N.C. Tam United States 13 272 1.2× 138 0.8× 131 0.9× 53 0.5× 123 1.6× 23 776
Anthony R. Soames United Kingdom 16 317 1.3× 223 1.3× 148 1.1× 59 0.6× 150 1.9× 31 766
Jae‐Ho Shin South Korea 16 138 0.6× 321 1.9× 125 0.9× 33 0.3× 78 1.0× 33 710
Hironori Takagi Japan 19 232 1.0× 317 1.9× 105 0.8× 48 0.5× 156 2.0× 67 1.0k
Daniel R. Hallinger United States 12 119 0.5× 175 1.0× 105 0.8× 52 0.5× 30 0.4× 17 548
Ruixin Hao United States 9 274 1.2× 155 0.9× 172 1.2× 38 0.4× 54 0.7× 17 649
Raegan O’Lone United States 11 336 1.4× 125 0.7× 319 2.3× 97 0.9× 177 2.2× 16 824
Bernard Vannier France 9 233 1.0× 206 1.2× 55 0.4× 60 0.6× 188 2.4× 18 780
Hitoshi Funabashi Japan 12 279 1.2× 84 0.5× 53 0.4× 33 0.3× 44 0.6× 28 588

Countries citing papers authored by Erik Ullerås

Since Specialization
Citations

This map shows the geographic impact of Erik Ullerås's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Ullerås with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Ullerås more than expected).

Fields of papers citing papers by Erik Ullerås

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik Ullerås. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Ullerås. The network helps show where Erik Ullerås may publish in the future.

Co-authorship network of co-authors of Erik Ullerås

This figure shows the co-authorship network connecting the top 25 collaborators of Erik Ullerås. A scholar is included among the top collaborators of Erik Ullerås based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik Ullerås. Erik Ullerås is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Oskarsson, Agneta, Erik Ullerås, & Åsa Ohlsson. (2016). Acetaminophen Increases Aldosterone Secretion While Suppressing Cortisol and Androgens: A Possible Link to Increased Risk of Hypertension. American Journal of Hypertension. 29(10). 1158–1164. 7 indexed citations
2.
Ullerås, Erik, et al.. (2012). Differentiation of mast cell subpopulations from mouse embryonic stem cells. Journal of Immunological Methods. 382(1-2). 160–166. 11 indexed citations
3.
Mattsson, Anna, Erik Ullerås, Johan Patring, & Agneta Oskarsson. (2012). Albendazole causes stage-dependent developmental toxicity and is deactivated by a mammalian metabolization system in a modified zebrafish embryotoxicity test. Reproductive Toxicology. 34(1). 31–42. 23 indexed citations
4.
Carlsson, Gunnar, Johan Patring, Erik Ullerås, & Agneta Oskarsson. (2011). Developmental toxicity of albendazole and its three main metabolites in zebrafish embryos. Reproductive Toxicology. 32(1). 129–137. 31 indexed citations
5.
6.
Ohlsson, Åsa, Erik Ullerås, Nina Cedergreen, & Agneta Oskarsson. (2010). Mixture effects of dietary flavonoids on steroid hormone synthesis in the human adrenocortical H295R cell line. Food and Chemical Toxicology. 48(11). 3194–3200. 22 indexed citations
7.
Gulliksson, M., et al.. (2010). Mast Cell Survival and Mediator Secretion in Response to Hypoxia. PLoS ONE. 5(8). e12360–e12360. 51 indexed citations
8.
Ohlsson, Åsa, Erik Ullerås, & Agneta Oskarsson. (2009). A biphasic effect of the fungicide prochloraz on aldosterone, but not cortisol, secretion in human adrenal H295R cells—Underlying mechanisms. Toxicology Letters. 191(2-3). 174–180. 46 indexed citations
9.
Ullerås, Erik, et al.. (2009). Biphasic hormonal responses to the adrenocorticolytic DDT metabolite 3-methylsulfonyl-DDE in human cells. Toxicology and Applied Pharmacology. 242(3). 281–289. 23 indexed citations
10.
Ullerås, Erik, Åsa Ohlsson, & Agneta Oskarsson. (2008). Secretion of cortisol and aldosterone as a vulnerable target for adrenal endocrine disruption — screening of 30 selected chemicals in the human H295R cell model. Journal of Applied Toxicology. 28(8). 1045–1053. 51 indexed citations
11.
Oskarsson, Agneta, Erik Ullerås, Kathryn E. Plant, J. P. Hinson, & Peter S. Goldfarb. (2006). Steroidogenic gene expression in H295R cells and the human adrenal gland: adrenotoxic effects of lindane in vitro. Journal of Applied Toxicology. 26(6). 484–492. 60 indexed citations
12.
Ullerås, Erik, Joanna Arkusz, Tove Ringerike, et al.. (2004). Development of the “Cell Chip”: a new in vitro alternative technique for immunotoxicity testing. Toxicology. 206(2). 245–256. 12 indexed citations
13.
Ringerike, Tove, et al.. (2004). Detection of immunotoxicity using T-cell based cytokine reporter cell lines (“Cell Chip”). Toxicology. 206(2). 257–272. 16 indexed citations
14.
Hedborg, Fredrik, Erik Ullerås, Lars Grimelius, et al.. (2003). Evidence for hypoxia‐induced neuronal‐to‐chromaffin metaplasia in neuroblastoma. The FASEB Journal. 17(6). 598–609. 15 indexed citations
15.
Ginjala, Vasudeva, Claes Holmgren, Erik Ullerås, et al.. (2002). Multiple cis Elements within theIgf2/H19 Insulator Domain Organize a Distance-dependent Silencer. Journal of Biological Chemistry. 277(8). 5707–5710. 4 indexed citations
16.
Ullerås, Erik, et al.. (2001). Inhibition of Histone Deacetylase Activity Causes Cell Type-Specific Induction of the PDGF-B Promoter Only in the Absence of Activation by Its Enhancer. Experimental Cell Research. 270(2). 188–198. 7 indexed citations
17.
18.
Kanduri, Chandrasekhar, Claes Holmgren, Marcel Pilartz, et al.. (2000). The 5′ flank of mouse H19 in an unusual chromatin conformation unidirectionally blocks enhancer–promoter communication. Current Biology. 10(8). 449–457. 78 indexed citations
19.
Miller, Stephen J., et al.. (1998). A Novel Type of Regulatory Element is Required for Promoter-specific Activity of the PDGF-B Intronic Enhancer Region. Growth Factors. 16(2). 137–151. 1 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Masahiro Takeyoshi Breakdown of academic impact, for papers by Neville N.C. Tam Breakdown of academic impact, for papers by Anthony R. Soames Breakdown of academic impact, for papers by Jae‐Ho Shin Breakdown of academic impact, for papers by Hironori Takagi Breakdown of academic impact, for papers by Daniel R. Hallinger Breakdown of academic impact, for papers by Ruixin Hao Breakdown of academic impact, for papers by Raegan O’Lone Breakdown of academic impact, for papers by Bernard Vannier Breakdown of academic impact, for papers by Hitoshi Funabashi
Rankless by CCL
2026